SYRS Oct 2024 5.000 put
OPR - OPR Delayed Price. Currency in USD
Add to watchlist
As of 12:33PM EDT. Market open.
| Previous Close | 1.1000 |
| Open | 1.1000 |
| Bid | 0.7000 |
| Ask | 1.4500 |
| Strike | 5.00 |
| Expire Date | 2024-10-18 |
| Day's Range | 1.0000 - 1.1000 |
| Contract Range | N/A |
| Volume | |
| Open Interest | 2 |
- GuruFocus.com
Syros Pharmaceuticals Inc (SYRS) (Q1 2024) Earnings Call Transcript Highlights: Strategic ...
Explore key updates on clinical trials, financial shifts, and strategic insights from Syros Pharmaceuticals' Q1 2024 earnings call.
- Thomson Reuters StreetEvents
Q1 2024 Syros Pharmaceuticals Inc Earnings Call
Q1 2024 Syros Pharmaceuticals Inc Earnings Call
Business WireSyros Reports First Quarter 2024 Financial Results and Provides a Corporate Update
CAMBRIDGE, Mass., May 14, 2024--Syros Pharmaceuticals (NASDAQ: SYRS), a biopharmaceutical company committed to advancing new standards of care for the frontline treatment of hematologic malignancies, today reported financial results for the quarter ended March 31, 2024 and provided a corporate update.
© 2024 Yahoo. All rights reserved.